|
⚲
|
| Keyboard |
| Ho Maykin
✚
|
|
|---|---|
| CIK # | 0001646395 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001646395] | |
| 4 | [0001646395] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ho Maykin | |
| Agios Pharmaceuticals Inc | |
| Kyntra Bio Inc | |
| BioMarin Pharmaceutical Inc | |
| Neumora Therapeutics Inc | |
| Parexel International Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2025-06-20 | Option exercise | 2,120 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common stock
|
2025-06-20 | Option exercise | 2,120 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2025-06-18 | Grant | 2,816 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Stock options (right to buy) · derivative
|
2025-06-18 | Grant | 15,768 | $0.00 | |
|
Kyntra Bio Inc FGEN
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 120,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 80,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 95,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 95,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 27,802 | ||
|
BioMarin Pharmaceutical Inc BMRN
Common Stock
|
2025-05-20 | Grant | 6,650 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 95,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 95,586 | ||
|
Agios Pharmaceuticals Inc AGIO
Stock options (right to buy) · derivative
|
2024-06-20 | Grant | 11,774 | $0.00 | |
| showing 20 of 76 most recent transactions | |||||